Tolerogenic Efficacy and Safety of Apoptotic Donor Leukocytes and Transient Immunosuppression withASKP1240, Rapamycin, Etanercept, and Tocilizumab in a Preclinical Islet Allotransplant Model inCynomolgus Monkeys

Project: Research project

Project Details

Description

Tolerogenic Efficacy and Safety of Apoptotic Donor Leukocytes and Transient Immunosuppression with ASKP1240, Rapamycin, Etanercept, and Tocilizumab in a Preclinical Islet Allotransplant Model in Cynomolgus Monkeys
StatusActive
Effective start/end date10/1/199/30/21

Funding

  • DIABETES-FREE, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.